Drugs Information:
Pirfenidone
Basic Information
|
|
||
| ID | DDInter1477 | |
| Drug Type | small molecule | |
| Molecular Formula | C12H11NO | |
| Molecular Weight | 185.222 | |
| CAS Number | 53179-13-8 | |
| Description | Pirfenidone is a synthetic pyridone drug.[A251370] It is an antifibrotic agent with anti-inflammatory and antioxidant properties [A251370] that is used to treat idiopathic pulmonary fibrosis (IPF),[L26801] which is a chronic, progressive form of interstitial pneumonia.[A251370] While its mechanism of action is not yet fully understood, pirfenidone is proposed to primarily regulate tumor necrosis factor (TNF) pathways and modulate cellular oxidation.[A251365] The FDA first approved pirfenidone alongside [nintedanib] as one of the first drugs to treat IPF.[A251165] | |
| ATC Classification | L04AX05 | |
| IUPAC Name | 5-methyl-1-phenyl-1,2-dihydropyridin-2-one | |
| InChI | ISWRGOKTTBVCFA-UHFFFAOYSA-N | |
| Canonical SMILES | CC1=CN(C(=O)C=C1)C1=CC=CC=C1 | |
| Useful Links | DrugBank ChEBI PubChem Substance ChemSpider BindingDB Wikipedia ChEMBL ZINC | |
Interactions with
Pirfenidone
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|